Patents by Inventor Tetsuya HARAKUNI

Tetsuya HARAKUNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220296697
    Abstract: Provided is PCV2 VLP that can be used as a vaccine for use in the field of animal husbandry and that has high molecular stability against physicochemical load. A fusion protein according to the present invention includes a capsid protein of porcine circovirus type 2 and an immunoglobulin-binding domain.
    Type: Application
    Filed: June 23, 2020
    Publication date: September 22, 2022
    Inventors: Takeshi ARAKAWA, Yukihiro TAMAKI, Kenichi YAMAZAKI, Jinya YAMADA, Nozomi TAIRA, Hirotaka UEFUJI, Ikuko YONAMINE, Tetsuya HARAKUNI, Rui YAMAGUCHI
  • Patent number: 10253072
    Abstract: The present invention is intended to provide an egg drop syndrome (EDS) vaccine that is capable of effectively preventing EDS and can be stably supplied. The EDS vaccine provided to this end contains as an active ingredient fused protein in which a polypeptide having a coiled-coil forming unit is bound to the knob region in the fiber protein of EDS virus (EDSV).
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: April 9, 2019
    Assignee: KM Biologics Co., Ltd.
    Inventors: Kenichi Yamazaki, Kiyohiko Andoh, Ryuichi Sakamoto, Kiyotaka Suenaga, Takeshi Arakawa, Hirotaka Uefuji, Tetsuya Harakuni, Takeshi Miyata
  • Patent number: 9701724
    Abstract: A purpose is to provide a vaccine which can prevent porcine edema disease in farms where porcine edema disease is anticipated. Meeting this purpose is a vaccine that is a fusion protein in which Stx2eB and a polypeptide having a coiled-coil forming unit are joined or a multimer of the fusion protein, and by immunizing pigs with this vaccine, it is possible to induce potent neutralizing antibodies and to defend against the onset of porcine edema disease.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: July 11, 2017
    Assignees: The Chemo-Sero-Therapeutic Research Institute, Jectas Innovators Company Limited
    Inventors: Kenji Yokogawa, Takashi Waki, Yoko Honda, Hirotaka Uefuji, Tomomitsu Sewaki, Takeshi Arakawa, Tetsuya Harakuni, Takeshi Miyata
  • Publication number: 20170044217
    Abstract: The present invention is intended to provide an egg drop syndrome (EDS) vaccine that is capable of effectively preventing EDS and can be stably supplied. The EDS vaccine provided to this end contains as an active ingredient fused protein in which a polypeptide having a coiled-coil forming unit is bound to the knob region in the fiber protein of EDS virus (EDSV).
    Type: Application
    Filed: March 16, 2015
    Publication date: February 16, 2017
    Applicants: The Chemo-Sero-Therapeutic Research Institute, Jectas Innovators Company Limited
    Inventors: Kenichi YAMAZAKI, Kiyohiko ANDOH, Ryuichi SAKAMOTO, Kiyotaka SUENAGA, Takeshi ARAKAWA, Hirotaka UEFUJI, Tetsuya HARAKUNI, Takeshi MIYATA
  • Publication number: 20150361142
    Abstract: A purpose is to provide a vaccine which can prevent porcine edema disease in farms where porcine edema disease is anticipated. Meeting this purpose is a vaccine that is a fusion protein in which Stx2eB and a polypeptide having a coiled-coil forming unit are joined or a multimer of the fusion protein, and by immunizing pigs with this vaccine, it is possible to induce potent neutralizing antibodies and to defend against the onset of porcine edema disease.
    Type: Application
    Filed: October 18, 2013
    Publication date: December 17, 2015
    Applicants: The-Chemo-Sero-Therapeutic Research Institute, Jectas Innovators Company Limited
    Inventors: Kenji YOKOGAWA, Takashi WAKI, Yoko HONDA, Hirotaka UEFUJI, Tomomitsu SEWAKI, Takeshi ARAKAWA, Tetsuya HARAKUNI, Takeshi MIYATA